Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Company Profile Unicycive Therapeutics Inc UNCY

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb RZB 012 for the treatment of hyperphosphatemia in patients with chronic kidney... see more

Showcase News Releases

Showcase news

Green Bridge Metals Corporation
Green Bridge Metals Obtains Permit and Signs Contract Agreement to Conduct a Diamond Core Drill Program at Its Titac Deposit
Highland Copper Company Inc.
Highland Copper Signs Definitive Agreement for Sale of 34% Interest in White Pine for US$30 Million
Lomiko Metals Inc.
Lomiko Metals Identifies New Rare Earth Element ("REE") Anomalies at the Yellow Fox Critical and Precious Metals Property in Central Newfoundland

More Showcase News Releases »